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An important but largely unmet challenge in understanding the mechanisms that govern the formation of specific
organs is to decipher the complex and dynamic genetic programs exhibited by the diversity of cell types within the
tissue of interest. Here, we use an integrated genetic, genomic, and computational strategy to comprehensively
determine the molecular identities of distinct myoblast subpopulations within the Drosophila embryonic mesoderm at
the time that cell fates are initially specified. A compendium of gene expression profiles was generated for primary
mesodermal cells purified by flow cytometry from appropriately staged wild-type embryos and from 12 genotypes in
which myogenesis was selectively and predictably perturbed. A statistical meta-analysis of these pooled datasets—
based on expected trends in gene expression and on the relative contribution of each genotype to the detection of
known muscle genes—provisionally assigned hundreds of differentially expressed genes to particular myoblast
subtypes. Whole embryo in situ hybridizations were then used to validate the majority of these predictions, thereby
enabling true-positive detection rates to be estimated for the microarray data. This combined analysis reveals that
myoblasts exhibit much greater gene expression heterogeneity and overall complexity than was previously
appreciated. Moreover, it implicates the involvement of large numbers of uncharacterized, differentially expressed
genes in myogenic specification and subsequent morphogenesis. These findings also underscore a requirement for
considerable regulatory specificity for generating diverse myoblast identities. Finally, to illustrate how the
developmental functions of newly identified myoblast genes can be efficiently surveyed, a rapid RNA interference
assay that can be scored in living embryos was developed and applied to selected genes. This integrated strategy for
examining embryonic gene expression and function provides a substantially expanded framework for further studies
of this model developmental system.
Citation: Estrada B, Choe SE, Gisselbrecht SS, Michaud S, Raj L, et al. (2006) An integrated strategy for analyzing the unique developmental programs of different myoblast
subtypes. PLoS Genet 2(2): e16.
Introduction
Transcriptional regulation plays a central role in metazoan
development by establishing cell-speciﬁc patterns of gene
expression that represent coordinate responses to extrinsic
signals and intrinsic programming [1,2]. Thus, detailed
knowledge of the genes that are spatially and temporally
coexpressed at the cellular level in a particular developmental
context will not only provide insight into the logic of
transcriptional networks but also deﬁne the downstream
effectors of morphogenesis. Given the cellular diversity
present in most tissues, it would be ideal to derive the entire
genetic program of each individual cell type and to
determine the response of each differentially expressed gene
to perturbations of the pathways that regulate formation of
that organ. Deﬁning such cell-speciﬁc gene expression
signatures and mapping the sequential steps involved in
their generation are both essential to achieving a systems-
level view of development [3,4].
Traditional studies have monitored only one or a few cell-
type speciﬁc markers at a time using different genetic
backgrounds to perturb the developmental process of
interest. In many cases, such approaches have yielded sets
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ceptual underpinnings for considering development in the
broader terms of component interactions and network
architecture [5,6]. However, to test the generality of hypoth-
eses derived from the study of small numbers of genes, it is
essential to acquire a comprehensive assessment of the gene
expression changes occurring in response to a known set of
developmental regulators.
Elaborating an integrated and systematic experimental
approach to identify and functionally characterize such genes
and their cis-regulatory sequences in a metazoan model
organism remains a signiﬁcant and largely unsolved chal-
lenge. In yeast, pooled expression proﬁles derived for
multiple genotypes and chemical treatments have proved
extremely valuable for dissecting biological pathways [7]. In
principle, it should be possible to generate equally illuminat-
ing expression proﬁle compendia for the development of
multicellular organisms. Large numbers of datasets have been
combined in a few cases for this purpose [8,9], but these
studies did not focus on a particular aspect of development.
Here, we have used such a comprehensive approach to
examine the molecular identities of myoblast subtypes in the
Drosophila embryo, results that yield new information about
the composition of the muscle regulatory network.
Myogenesis initiates with the segregation of two types of
myoblasts from the somatic mesoderm: founder cells (FCs)
and fusion-competent myoblasts (FCMs) [10]. Each FC
possesses a unique identity and seeds the formation of an
individual myotube by fusing with the more homogeneous
population of FCMs. Of the known early muscle-speciﬁc
genes, some are speciﬁc to only one myoblast type, while
others are expressed in both. Many of these genes encode
transcription factors that are essential for myoblast speciﬁca-
tion [11–16]. Intercellular signals act in different combina-
tions to promote the formation of FCs and FCMs [10,17]. This
process is best understood for a subset of FCs that express even
skipped (eve) [18–21]. Wingless (Wg, a Wnt family member) and
Decapentaplegic (Dpp, a member of the bone morphogenetic
protein superfamily) ﬁrst cooperate to render a large domain
of mesodermal cells competent to respond to a subsequent
inductive signal mediated by two receptor tyrosine kinases
(RTKs), an epidermal growth factor (EGF) receptor (EGFR)
and the ﬁbroblast growth factor (FGF) receptor (FGFR)
encoded by heartless (htl). Localized RTK activation within
the competence domain stimulates the Ras pathway and the
formation of Eve-expressing equivalence groups [18]. Lateral
inhibitory signaling by Notch then allows a single Eve
progenitor to emerge from each equivalence group under
thecontinued inﬂuence of Ras [19], with the remaining Notch-
inhibited cells assuming an FCM identity characterized by
expression of lame duck (lmd) [14–16]. Since FCs are derived by
the asymmetric division of progenitors [22,23], the Ras
pathway favors FC formation, while Notch promotes FCM
development from mesodermal equivalence groups.
Integration of the Wg, Dpp, and Ras pathways occurs
through the direct convergent regulation of eve by the three
corresponding signal-activated transcription factors bound to
a speciﬁc enhancer in the context of twomesodermal selectors
[24–26]. Thus, distinct myoblast identity codes are generated
by the combinatorial functions of Wg, Dpp, EGF, FGF, and
Notch signals. These signaling codes are in turn mirrored in
transcriptional codes that induce the changes in gene
expression that are characteristic of individual FCs and FCMs.
Collectively, this knowledge provides the logical foundation
for genomic and computational investigations of muscle gene
transcriptional regulation in the Drosophila embryo.
Gene expression proﬁling of the Drosophila embryonic
mesoderm has been undertaken in several prior studies. In
one approach, mutations in early dorsoventral patterning
genes were used to eliminate or overproduce mesodermal
cells, and genes whose expression is enriched in the
mesoderm were identiﬁed by microarray analysis [14,27]. A
modiﬁcation of this approach in which the Ras or Notch
pathway was constitutively activated in a Toll
10b mutant—a
genetic background that drastically disrupts gastrulation and
converts the entire embryo to mesoderm—led to the
identiﬁcation of a small number of genes that are speciﬁc
to FCs or FCMs [28]. However, the latter study was limited by
several factors, including the complete lack of inductive
ectoderm and its differentiated derivatives in Toll
10b embryos,
the absence of Dpp in these embryos, the disruption of
normal cellular interactions within the overproduced meso-
derm, independent validation of only a few microarray
predictions so that a true-positive detection rate could not
be reliably estimated, and the use of a cDNA microarray that
represented only 40% of the genes in the entire Drosophila
genome. It is likely, therefore, that many more FC and FCM
genes remain to be discovered.
To address this question, we designed a different strategy
for analyzing cell type–speciﬁc genetic programs for a
complex tissue that circumvents the previously encountered
difﬁculties and is more generally applicable. This approach
integrates genetic perturbations of development, puriﬁcation
of primary embryonic cells of interest, microarray-based
genomewide transcriptional proﬁling, statistical meta-analy-
sis of the pooled gene expression datasets, and large-scale
validation by in situ hybridization of gene expression
patterns predicted by the computational analysis. Applying
this strategy, we identiﬁed and validated several hundred
genes that are uniquely expressed in FCs, FCMs, or both
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Synopsis
Animal development requires cells in complex organs to acquire
distinct identities. During the development of the body wall
musculature of the fruit fly, a pool of apparently identical cells
gives rise to two types of muscle precursors, both of which are
required for the appearance of functioning muscles. These identities
depend on broad programs of gene expression. The authors
attempt to dissect the complements of expressed genes that define
these two different cell types by integrating modern methods in
genetics, genomics, and informatics. By purifying informative cells
from normal embryos and mutants that perturb muscle develop-
ment, assaying their genomewide gene expression programs, and
combining experiments statistically, they have identified fivefold
more founder-specific genes than were previously suspected to
characterize this cell type. The expression patterns of hundreds of
genes were examined in whole embryos to test the statistical
predictions, permitting the authors to estimate how many more cell
type–specific genes remain to be discovered. Finally, dozens of the
genes highlighted by these methods were tested for direct
involvement in muscle development, and several new players in
this process are reported. The integrated strategy used here can be
generalized for studying genetic programs in other complex tissues.myoblast types. Finally, we used in vivo RNA interference
(RNAi) to rapidly assess the myogenic functions of several
newly identiﬁed myoblast genes. In a separate but comple-
mentary effort, information derived from the present studies
was applied to a new computational method for analyzing the
relative contribution of individual transcription factor bind-
ing sites to combinatorial transcriptional codes (A. A.
Philippakis, B. Busser, S. S. Gisselbrecht, F. S. He, B. Estrada,
A. M. Michelson, and M. L. Bulyk, unpublished data). Taken
together, the systematic strategy used here provides signiﬁ-
cant new insights into embryonic myogenesis and represents
an integrated experimental framework that can be applied to
related investigations in other developmental contexts.
Results
Purification of Mesodermal Cells by Flow Cytometry
To increase the sensitivity of detecting myoblast transcripts
in microarray expression proﬁling experiments, we ﬁrst
developed a method to purify both wild-type and mutant
cells of interest from whole Drosophila embryos. Green
ﬂuorescent protein (GFP) was targeted to the mesoderm
using the Gal4-UAS technique, with twi-Gal4 as a speciﬁc
driver and a UAS-GFP transgene as the reporter (Figure 1A)
[29,30]. We used the binary nature of this expression system
to target GFP not only in a tissue-speciﬁc manner but also
such that only mutant cells would be labeled for any loss-of-
function genotype. This goal was accomplished by recombin-
ing the twi-Gal4 construct onto a selected mutant chromo-
some in one strain and the UAS-GFP reporter onto the same
mutant chromosome in a second strain. Crossing these two
strains results in GFP expression only in mutant mesodermal
cells; neither wild-type mesoderm nor mutant nonmesoder-
mal cells express GFP in progeny embryos (Figure 1B).
Similarly, it is possible to introduce a second UAS transgene
that encodes a constitutively activated or dominant negative
form of a signal transduction component or transcription
factor as another means of perturbing normal development
[19,24]. Most important, selection of an appropriate combi-
nation of speciﬁc Gal4 lines and additional genetic back-
grounds enables this strategy to be targeted to the
development of any tissue or cell type.
Embryos were collected, incubated to the stage during
which FCs and FCMs are speciﬁed, and then gently
dissociated to yield a single cell suspension. GFP-expressing
and non–GFP-expressing cells were separated by ﬂuorescence
activated cell sorting (FACS), total cellular RNA was isolated
from each population, and the RNA was labeled for hybrid-
ization to Affymetrix GeneChip arrays (Figure 1C). A
representative ﬂow cytometry scatterplot for puriﬁcation of
wild-type mesodermal cells is illustrated in Figure 1D. Cell-
sorting parameters were optimized for achieving greater than
90% cell purity in all experiments.
Identification of Genes with Enriched Expression in Wild-
Type Mesodermal Cells
We ﬁrst compared the RNA proﬁles for GFP-positive
versus GFP-negative cells puriﬁed from wild-type embryos.
Using the statistical methods detailed in Protocol S1, Analysis
Method A, 335 probe sets were identiﬁed to have higher
expression levels in GFP-positive cells than in the rest of the
embryo. Of these, approximately 200 had not previously been
described as having mesodermal expression. To validate these
results, we undertook in situ hybridizations in wild-type
embryos using probes corresponding to 207 genes enriched
in the GFP-positive population (including some that had been
described previously but had not been extensively charac-
terized). Combining these results with data from the
literature, we calculated a true-positive detection rate of
95.3% for genes enriched in GFP-expressing cells. Genes
expressed in a wide variety of mesodermal derivatives were
identiﬁed, including somatic and visceral muscle precursors,
fat body, hemocytes, and heart (Figure S1 and Table S1).
Having established the feasibility of expression proﬁling
FACS-puriﬁed mesodermal cells, further experiments were
designed to more completely characterize the expression
programs of different myoblast subpopulations.
Prediction of Candidate Myoblast-Specific Genes from a
Compendium of Mesodermal Gene Expression Profiles
A key feature of our experimental strategy is the use of
speciﬁc genetic backgrounds to selectively perturb gene
expression based on existing knowledge of relevant devel-
opmental pathways. The intercellular signaling network
involved in Drosophila FC and FCM development is shown in
Figure 2 [10,17]. In the few examples studied at single cell
resolution, the RTK/Ras pathway was found to induce FC
identities, whereas Notch had a similar function for FCMs [14–
16,18,19,31]. To assess whether these two signals are differ-
Stage 11 embryos
Cell dissociation
FACS
Isolation and labeling of
total cellular RNA
Affymetrix GeneChip hybridization
Statistical analysis and comparison
of gene expression profiles:
1. WT GFP+ (mesodermal) vs. GFP-
    (non-mesodermal) RNAs
2. WT GFP+ (mesodermal) vs. 
    genetically manipulated GFP+
    (mesodermal) RNAs
Figure 1. Experimental Strategy for Transcriptional Profiling of Purified
Embryonic Mesodermal Cells
(A) Embryos transgenic for Gal4 under the control of the twi promoter
and GFP under UAS control express GFP specifically in mesodermal cells.
(B) If twi-Gal4 and UAS-GFP transgenes are maintained on mutant
chromosomes, only homozygous mutant mesoderm expresses GFP
when the resulting flies are mated.
(C) Overview of the workflow to obtain genomewide expression
information on mesodermally enriched and genotype-responsive genes.
(D) A representative FACS experiment, showing initial sorting of all cells
from wild-type embryos (top; upper box represents GFP-positive sort
window [blue], lower box represents GFP-negative sort window [green])
and resorting of the purified cell population (bottom). Sorting
parameters routinely achieved greater than 90% pure GFP-positive cells.
DOI: 10.1371/journal.pgen.0020016.g001
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we used a dumbfounded (duf) enhancer trap line as a global FC
marker [32,33], and an antibody directed against Lmd as a
marker of all FCMs [15] (Figure 2C). Mesodermal expression of
either constitutively activated EGFR or FGFR had the same
effect: FCs were markedly overproduced at the expense of
FCMs in all regions of the somatic mesoderm (Figure 2D and
2E). Conversely, Notch activation blocked formation of most,
if not all, FCs, with either no effect or perhaps a slight increase
in FCMs (Figure 2F). Thus, the EGFR/FGFR and Notch
pathways have opposing effects on the determination of
virtually all FCs and FCMs. Given these results, we predicted
that loss- and gain-of-function genetic manipulations of these
pathways would generate global changes in myoblast-speciﬁc
gene expression, as indicated in Figure 2B, and that these
patterns should facilitate the rapid categorization of FC and
FCM genes on a genomewide scale.
A compendium of gene expression proﬁles speciﬁcally
targeted to muscle development was generated for meso-
dermal cells puriﬁed from 12 genetic backgrounds (Figure
2B). A meta-analysis was then designed to optimize the
assignment of genes to one or the other myoblast category
based on each gene’s collective behavior in the expression
proﬁle compendium. For example, any gene that is upregu-
lated relative to wild-type in RTK/Ras, Dpp, or Wg pathway-
activating conditions, upregulated in a Dl mutant, down-
regulated with Notch activation, and downregulated in a wg
mutant should have a high probability of being expressed in
muscle FCs. Of note, any one genotype alone detected less
than 40% of known FC genes and less than 30% of known
FCM genes (at q ¼ 0.01; Figure 3A), suggesting that many
more genes that are speciﬁcally transcribed in each of these
cell types remain to be identiﬁed. We therefore factored into
the meta-analysis not only the expected trends in gene
expression for each genetic manipulation but also a weight
factor that reﬂects the relative contribution of each genotype
to the detection of known myoblast-speciﬁc genes (Protocol
S1, Analysis Method E).
To score the genes with respect to FC- or FCM-like
expression response, we used a statistical metric (‘‘T’’) [34],
which is a weighted sum of the t-statistics from each genotype
versus wild-type comparison (Protocol S1, Analysis Method
E). The weights in this sum were optimized to account for the
differential sensitivity of the genotypes in detecting training
sets of FC or FCM genes (Figure 3A). To avoid introducing
biases for or against any genotype, these training sets
primarily contained the mesodermally enriched genes that
had been veriﬁed by in situ hybridization in this study to be
FC or FCM genes, as well as known genes of each class taken
from the literature, for a total of 43 FC probe sets and 42
FCM probe sets (Table S2). Clear distinctions exist between
the optimized weight proﬁles derived for FC and FCM genes
(Figure S2A and S2C), consistent with each genotype differ-
entially affecting gene expression in the two myoblast types.
Using these two sets of weights, we then calculated two T-
scores for every gene, one representing FC-like and the other,
FCM-like, expression responses.
When all genes were ordered based on their FC and FCM
T-scores, both training sets were preferentially located at the
tops of their respective ranks (P , 10
 13 for FC genes and P ,
10
 14 for FCM genes, using the Wilcoxon-Mann-Whitney U
test; Table S2 and Figure 3B). We also were able to assign
signiﬁcance level estimates to the T-scores by applying
random permutations to the expression datasets. These
calculations yielded a q-value for each gene, which is the
predicted false-positive fraction (number false positive/
number called positive) when using that gene’s T-score as
the cutoff for signiﬁcance [35]. Figure 3A shows the improved
sensitivity achieved by our meta-analysis for the detection of
FC and FCM genes. When combining multiple datasets, we
were able to detect more known FC and FCM genes at a given
q-value than when using any genotype individually. This
outcome is not entirely the result of simply having more
replicates, since the efﬁcacy of the meta-analysis also beneﬁts
from the inclusion of related results from multiple genotypes
that independently and differentially perturb the develop-
mental process of interest (see Discussion).
From the targeted expression proﬁle compendium, we
predicted a total of 373 (q ¼ 0.002) and 276 (q ¼ 0.002) genes
with FC- and FCM-like responses, respectively (Protocol S1,
Analysis Method F; Figure S2B and S2D). After extensive
Figure 2. Differential Genetic Inputs to Two Classes of Somatic
Myoblasts
(A) A network of signaling molecules and transcription factors is known
to positively and negatively regulate the specification of muscle FCs and
FCMs.
(B) Predicted behavior of genes specific to these cell types when key
components of the network are genetically perturbed (þ indicates
increased mesodermal expression relative to wild-type;  , decreased
expression; 0, no change).
(C–F) Expression of an FC marker (duf-lacZ, magenta) and an FCM marker
(Lmd, green) show that in wild-type somatic mesoderm (C), FCs comprise
a small number of individual cells, and the remainder of somatic
myoblasts are FCMs. Constitutive activation of the EGF receptor (D) or
FGF receptor (E) greatly expands the FC population at the expense of
FCMs; remnant Lmd protein is excluded from nuclei. Conversely,
constitutive activation of Notch signaling (F) largely eliminates the FC
population with either no effect or perhaps a slight increase in FCMs
apparent at the indicated resolution.
DOI: 10.1371/journal.pgen.0020016.g002
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Myoblast Developmental Program Analysisfollow-up using in situ hybridization, lists of validated FC,
FCM, or FC þ FCM genes were then queried for relative
enrichment of Gene Ontology (GO) terms (Table S3). For FC
genes, overrepresented molecular function categories include
transcriptional regulation, transmembrane receptor protein
kinase activity, cytoskeletal protein binding, and small
GTPase regulatory/interacting proteins, with enrichment for
biological processes such as cell surface receptor–linked
signal transduction, cell adhesion, cell motility, small GTPase
mediated signal transduction, and mesoderm cell fate
speciﬁcation. In contrast, the validated FC þ FCM gene
candidates are biased toward ribosome and protein biosyn-
thesis. There were too few validated FCM genes to yield many
statistically enriched GO terms, but the two that passed our
cutoff criteria were muscle and mesoderm development.
We next clustered the expression proﬁling data derived for
all genotypes and found that both the training sets and
subsequently identiﬁed FC and FCM genes segregate into two
broad subclusters for each cell type (Figure 3C). FC1 genes
largely follow the expected responses to the set of multi-
factorial genetic perturbations (Figure 2B), whereas FC2
genes have an unanticipated response to wg loss-of-function
(increased expression) and a stronger than expected Dpp
gain-of-function response. Such an aberrant wg effect can
Figure 3. Statistical Meta-Analysis of an Expression Profiling Compendium for Predicting Myoblast-Specific Genes
(A) Detection curves showing the number of probe sets from the training set detected, as a function of q-value, for FC genes (left) and FCM genes
(right). In each panel, the predictive value of individual genotype/wild-type comparisons (various colors; see legend) are compared to randomly
generated rankings (thin black lines) and to composite rankings derived from a weighted combination of all datasets (gray). To avoid introducing biases
for or against any genotype, the training sets were composed of known genes from the literature as well as the mesodermally enriched genes that had
been verified by in situ hybridization in this study to be FC or FCM genes, for a total of 43 FC probe sets and 42 FCM probe sets (Table S2).
(B) All probe sets on the chip were ranked according to their degree of FC-like (red axis) or FCM-like (blue axis) expression pattern, using their weighted
T-scores. The ranks of the training set probe sets (FC in red, FCM in blue) within their respective axes are plotted as thin vertical lines, revealing the
extent to which optimization concentrates each training set at the top of its corresponding rank. P values shown are from the Wilcoxon-Mann-Whitney
U test. Thick lines reflect the merging of individual thin vertical lines.
(C) Clustering of genotype data (first 12 rows) by self-organizing maps produces two clusters enriched for known and predicted FC genes (FC1 and FC2,
white boxes) and two clusters enriched for known and predicted FCM genes (FCM1 and FCM2, white boxes). For reference, FC- and FCM-weighted T-
scores are depicted (yellow: T . 0, blue: T , 0, and saturated yellow/blue colors correspond to the 98% percentile of the absolute T-values). Also
highlighted are the locations of validated FC and FCM genes (yellow lines), as well as mesodermal fold change levels (‘‘meso enrich’’).
DOI: 10.1371/journal.pgen.0020016.g003
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Myoblast Developmental Program Analysisoccur for somatic FC genes that are also expressed in the
visceral mesoderm, which is expanded in wg mutant embryos
[36,37]. Known FCM genes are predominantly located in
subcluster FCM1, in agreement with the canonical FCM
expression pattern (Figure 2B).
Validation of Results Derived from the Targeted
Expression Profile Compendium
To validate microarray meta-analysis predictions, in situ
hybridizations were performed for large numbers of genes
using embryos with informative genotypes. For example,
since Ras gain-of-function and Dl loss-of-function over-
produce FCs at the expense of FCMs [18,19,38,39], a gene
speciﬁcally expressed in FCMs or FCs should have reduced or
increased expression, respectively, in these genetic back-
grounds (Figure 4). Moreover, newly identiﬁed FC genes
coexpress duf, an established FC marker [33] (Figure 4D and
4H), while predicted FCM genes coexpress the known FCM
gene, lmd [14–16] (Figure 4M and 4R).
To assess the accuracy of the meta-analysis, we examined
how many true positives are found among the genes highly
ranked as being expressed in each type of myoblast (Table
S2). Of 213 randomly selected genes from among the top-
ranked 373 FC candidates, 118 (55%) were validated as
authentic FC genes, that is, actually expressed in founder cells
by embryonic in situ hybridizations in the above-mentioned
genetic backgrounds. When 123 of the predicted 276 FCM
genes were similarly examined by in situ hybridization, 18
(15%) were found to have FCM-speciﬁc expression patterns,
while an additional 40 (33%) were found to be expressed in
both FCs and FCMs. Taken together, these ﬁndings suggest
that, while FC gene predictions derived from the present
experimental design are very accurate, the hypothesized
speciﬁcity of the genetic manipulations for FCM genes is
confounded by genes that are expressed in both myoblast
types. Of note, this conclusion could only be derived from the
large-scale in situ hybridization data obtained here, experi-
ments that have not frequently been undertaken in other
transcriptional proﬁling studies to validate microarray
results. Using the present ﬁndings, it is apparent that a
previous microarray-based study also had a signiﬁcant false-
positive rate of FCM gene prediction, although the authentic
FC gene discovery rate in that case was comparably high.
However, it is important to note that signiﬁcantly fewer total
gene numbers were detected in the earlier study for both
myoblast classes [28] (see Table S1 for details). Pooling all of
the currently available data, 160 FC and 51 FCM genes are
known, of which 131 and 45, respectively, were identiﬁed and
validated in the present studies. Extrapolating from our
ﬁndings, we estimate that FCs and FCMs actually express a
total of about 321 and 82 unique genes, respectively (see
Protocol S1, Analysis Method F).
Differential Regulation of FCM Genes by the Zinc Finger
Transcription Factor, Lmd
Expression of the vast majority of newly identiﬁed FCM
genes requires lmd, which encodes a transcription factor that
is essential for FCM development [14–16] (Figure 4L and 4Q
and Table S1). However, four of the validated FCM-speciﬁc
genes (Figure 5) were unexpectedly found to be independent
Figure 4. Empirical Validation of Predicted FC and FCM Genes
CG14207 (A–D) and CG10275 (E–H) are representative FC genes identified in the present work with meta-analysis ranks of 6 and 11, respectively (Figure
3B and Table S1). RNA in situ hybridization shows that each is normally expressed in a characteristic subset of somatic myoblasts (A and E) and in an
expanded population in embryos in which Ras is ectopically activated (B and F) or that are mutant for Dl (C and G). Staining of in situ–hybridized
embryos with the founder marker duf-lacZ (orange nuclei: D and H) reveals extensive coexpression. CG10641 (I–M) and CG2708 (N–R) are representative
FCM genes ranked in the meta-analysis as 38 and 23, respectively. In wild-type embryos (I and N), they are expressed in the majority of somatic and
visceral myoblasts. This expression is largely lost in activated Ras embryos (J and O) and in the somatic mesoderm of Dl mutant embryos (K and P),
although the latter retain expression in the visceral mesoderm (arrows). Expression of these genes is lost in lmd mutant embryos (L and Q), and is
normally restricted to a subset of Lmd-expressing cells (orange nuclei: M and R).
DOI: 10.1371/journal.pgen.0020016.g004
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Further analysis revealed many genes that in general behave
like FCM genes but actually exhibit more complex region-
speciﬁc expression patterns. For example, some genes are lmd
dependent in dorsal and lateral regions of the embryo (Figure
5H, 5J, 5L, and 5N and data not shown) but have a ventral
expression domain that does not include all Lmd-positive
myoblasts (Figure 5E–5G). Furthermore, expression of these
latter genes in some ventral myoblasts responds to both Ras
activation and loss of Dl function in a manner akin to FC
rather than FCM genes (Figure 5I, 5K, and 5M), although they
are entirely FCM like in their dependence on lmd (Figure 5O).
In some but not all cases, genes expressed in the somatic
mesoderm that are lmd dependent do not require lmd for
their expression in the visceral mesoderm (compare Figures
4L and 4Q and Figures 5N and 5O; Table S1), underscoring
the differential response of such genes to loss of Dl function
in these two mesodermal subdivisions (Figure 4K and 4P).
These ﬁndings are summarized in Figure 5P and 5Q.
Functional Analysis of Newly Identified Myoblast Genes
To screen for the developmental functions of newly
identiﬁed myoblast genes, we modiﬁed a whole embryo RNAi
assay [40] to permit the rapid scoring of muscle patterning
phenotypes. Double-stranded RNAs (dsRNAs) were injected
into blastoderm embryos expressing a tau-GFP fusion protein
under myosin promoter control, which enables the complete
muscle pattern to be visualized after the embryos develop [41]
(Figure 6A and 6B). Injection of dsRNAs corresponding to
genes with known myogenic functions phenocopied their
genetic loss-of-function with complete penetrance, while a
nonspeciﬁc dsRNA had no effect [42–44] (Figure 6A–6D).
Since this assay involves a 1-d turnaround without further
embryo manipulation, multiple genes can be screened
simultaneously.
Selected RNAi results are shown in Figure 6E through 6K.
Injection of dsRNA derived from CG13503—an FCM-speciﬁc
gene that encodes verprolin, an actin binding protein—
causes a reduction in myoblast fusion (Figure 6E and 6F).
Based on the presence of single, unfused muscle cells in these
embryos, we have named CG13503 ‘‘solas’’ (sola means
‘‘alone’’). RNAi for CG17492—an FC-speciﬁc gene whose
mammalian ortholog is skeletrophin [45]—causes a more
severe loss of normal myoﬁbers and their replacement by
multinucleated myospheres, some of which extend short
processes (Figure 6G–6I). This phenotype is observed prior to
the onset of muscle contraction—which can be directly
visualized in living embryos—yet it becomes progressively
more severe as the muscles begin to contract (Figure 6J and
6K). The association of unattached myospheres with the
effects of CG17492 RNAi suggested to us the name ‘‘suelto’’
(suel means ‘‘loose’’). Small chromosomal deﬁciencies that
separately uncover sola and suel phenocopy the respective
RNAi effects (data not shown).
The live embryo RNAi assay also can be used to identify
genes involved in muscle function. We found that the muscle
Figure 5. Heterogeneity in the Regulation of FCM Gene Expression
(A–D) In situ hybridization of wild type and lmd mutant embryos with
NHP2 (A and B) and RpI135 (C and D) gene probes shows that expression
of these two FCM genes is independent of Lmd regulation.
(E–G) Subset of ventral Lmd-expressing myoblasts (orange nuclei)
without the expression of FCM markers such as sns, CG13503, and
CG10641 (arrowheads in E, F, and G, respectively).
(H–O) A subset of ventral myoblasts displays unexpected behavior. Wild-
type expression of sns is observed in lateral (H) and ventral (I) somatic
myoblasts (arrowhead in H). Lateral somatic myoblast expression is
uniformly downregulated in Ras gof (J), Dl mutant (L), and lmd mutant (N)
embryos, although visceral mesoderm (VM) expression is largely
unchanged. A small ventral population of sns-expressing myoblasts
remainsinembryoswithconstitutiveRasactivation(K,arrowheads)orloss
of Dl (M), but expression in these cells is lost in lmd mutant embryos (O).
(P) Expression of previously described (‘‘canonical’’) FCM-specific genes
depends on Lmd, which is activated by Notch signaling and repressed by
Rassignaling;asubsetofFCMgenes(A–D)areunderthecontroloftheRas
andNotchsignalingpathwaysbutdonotrequireLmdfortheirexpression.
(Q) The majority of somatic FCMs (blue) express sns and lmd and require
Notch signaling for their specification; we have identified a subpopu-
lation of cells (brown) that express lmd but not sns or other FCM markers
(E–G) and additional cells (gray, including VM) that express sns even in
the absence of the Notch ligand Dl.
DOI: 10.1371/journal.pgen.0020016.g005
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dsRNA, but these muscles never contracted when compared
with age-matched control embryos (Video S1). CG2708 is
expressed only in FCMs (Figure 4N–4R) and encodes a
myosin-binding protein with homology to Caenorhabditis
elegans unc-45, for which loss-of-function mutations are
associated with muscle paralysis [46].
Finally, an RNAi phenotype was obtained for chicadee (chic)
that encodes a Drosophila proﬁlin homolog [47] that is
expressed speciﬁcally in FCMs. RNAi for chic is associated
with complete absence of cellularization at the blastoderm
stage (data not shown), presumably due to dsRNA effects on
both maternal and zygotic transcripts. Due to its maternal
expression and essential involvement in oogenesis, it has not
previously been possible to assess the early embryonic
functions of chic using germline clonal analysis [48], under-
scoring another advantage of the RNAi approach used here.
Discussion
We have used an integrated strategy for systematically
studying the development of a complex tissue by combining
genetic perturbations of a particular biological process,
computational analysis of a compendium of gene expression
proﬁles that is targeted to the tissue by FACS puriﬁcation of
the cells of interest, large-scale validation of predicted gene
expression patterns by whole embryo in situ hybridization,
and RNAi-based functional studies of newly discovered genes.
Speciﬁcally, we identiﬁed large numbers of genes that are
coexpressed in different subsets of myoblasts by analyzing
pooled microarray data obtained for embryonic mesodermal
cells puriﬁed from multiple genetic backgrounds in which
muscle development is selectively perturbed. A whole embryo
RNAi assay then revealed the developmental functions of
selected myoblast-speciﬁc genes. Collectively, the present
work contributes valuable information to a more detailed
understanding of the regulatory network governing somatic
myogenesis in the Drosophila embryo, provides a substantially
expanded framework for future studies of this developmental
process, and offers a uniﬁed experimental approach that can
be applied to other systems.
Transcriptional Profiling of Complex Tissues
Cell-speciﬁc genetic programs must be delineated in order
to fully understand how diverse cellular identities are
established during tissue and organ formation. Previous
studies have addressed various aspects of metazoan develop-
ment by combining genetic and genomic methods
[9,14,27,28,49–55]. While highly informative for temporal
aspects of gene expression in whole animals [50], in revealing
sex-biased transcription [53], or in yielding cell-speciﬁc wild-
type expression proﬁles [49,51,54,55], such studies have not
examined the global changes in gene expression that are
associated with genetic manipulations of regulatory pathways
affecting the tissue of interest. Mutants that perturb large
numbers of cells arising from subdomains of an embryonic
axis have been used to enrich for the detection of tissue-
speciﬁc transcripts, a strategy that works best for early aspects
of development [14,27,28]. However, this genetic approach
complicates the analysis of later steps in organogenesis since
tissue organization and intercellular communication are
severely disrupted by these major patterning mutations [28].
Perturbation of a single regulatory pathway in whole embryos
has also been used for the discovery of cell-speciﬁc genes, but
efforts like this have been limited by very high false-positive
detection rates because the signal from the cells of interest is
diluted by the rest of the embryo [52].
The present approach provides two major advantages for
determining the gene expression programs of separate cell
types in a developing embryo. First, isolating the tissue of
interest—even without purifying individual cell popula-
tions—substantially increases the sensitivity of microarray
Figure 6. RNAi Analysis of Selected Myoblast Genes
(A and B) Live embryos expressing a tau-GFP fusion protein under
control of the myosin heavy chain promoter and injected with an
inactive control double-stranded lacZ RNA have a wild-type mature
muscle pattern. Note, at high magnification (B), the complete absence of
unfused myoblasts at this stage.
(C and D) Injection of dsRNA for the known muscle fusion genes mbc (C)
and blow (D) phenocopy mutations in these genes.
(E and F) RNAi directed against the FCM gene CG13503 causes an overall
reduction and disorganization of muscle fibers (E), with persistence of
unfused myoblasts (arrowheads in F), consistent with a fusion defect.
(G–K) Injection of dsRNA for the FC gene CG17492 results in the
formation of multinucleate myospheres from only certain muscle fibers.
A severely affected embryo (G) demonstrates the complete sparing of
certain muscle groups, while other muscles appear as spheres (H) or as
compact masses with thin extensions (arrowhead, I). While some
abnormalities are apparent before any muscle contraction is visible (J),
the same embryo observed later (K) shows that some muscles that had
appeared morphologically normal have now formed myospheres
(compare arrowheads in J and K).
DOI: 10.1371/journal.pgen.0020016.g006
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pathways signiﬁcantly augments both the statistical and
biological power of the microarray compendium to resolve
cell-speciﬁc expression patterns. While independent replicas
of the same genotype yield statistical power, use of multiple
genotypes has the additional beneﬁt of reducing systematic
biases that may be associated with a single genetic manipu-
lation. Indeed, we found that different genotypes have
distinct capacities to detect FC versus FCM genes, suggesting
that perturbing multiple pathways is a more effective means
to query diverse cell types present in the isolated tissue. For
instance, the overall sensitivity of the approach is reﬂected in
the high FC meta-analysis rank obtained for eve (108), even
though it is expressed in less than 1% of mesodermal cells.
Puriﬁcation of speciﬁc cells and the inclusion of multiple
informative genotypes in the acquisition of genomewide
expression data for a particular tissue—what we have termed
a targeted expression proﬁle compendium—provide addi-
tional information that has not been available from prior
genomic studies of mesoderm development [14,27,28]. For
example, a related microarray analysis of myoblast gene
expression [28] predicted a total of only 33 FC and 48 FCM
genes compared with 373 and 276, respectively, predicted
here. Several important differences in experimental design
can account for the disparate outcomes of the two
approaches, including use of different numbers of genetic
perturbations of FC and FCM development (two in the
previous study versus 12 here), different microarray plat-
forms representing dissimilar fractions of the genome, and
the absence of Dpp as an FC determining signal in the
embryos used in the earlier study [28]. In this regard, we
found that Dpp contributes signiﬁcantly to FC gene
identiﬁcation, so its inclusion in any experimental analysis
of muscle development appears to be critical.
Our ﬁndings emphasize the importance of independently
validating microarray data and computational predictions of
genes expressed in different cell populations. Whereas whole
embryo in situ hybridizations revealed that the FC gene
prediction rate was very high, the fraction of true positive
FCM genes was considerably smaller when the same datasets
were analyzed using a similar rationale and statistical
methods. The in situ hybridization results further demon-
strated that the observed difference in the accuracy of FC and
FCM gene prediction rates is largely attributable to an
unanticipated number of genes expressed in both myoblast
types that, from the microarray data analysis alone, were
incorrectly scored as FCM-speciﬁc genes. This last outcome
most likely occurred because transcripts expressed in both
FCs and FCMs followed an FCM-speciﬁc pattern in the
genetic perturbation and microarray experiments owing to
the fact that FCMs greatly outnumber FCs in the puriﬁed cell
fraction. This issue notwithstanding, the integrated approach
we used facilitated the efﬁcient identiﬁcation of several
hundred genes having different myoblast-speciﬁc expression
patterns while entailing quite manageable false positive
detection rates.
The transcriptional proﬁling strategy elaborated here
offers an information-rich approach that can be applied to
other model organisms and developmental processes. Indeed,
because the present experiments employed a general meso-
dermal Gal4 driver, the existing compendium of expression
proﬁles should be applicable to mesodermal derivatives other
than somatic muscle. Consistent with this expectation, a
preliminary meta-analysis using a relevant subset of the
present data was effective in predicting genes with cardiac
expression (SEC and AMM, unpublished results). The
sensitivity and speciﬁcity of these analyses can be further
optimized by using the most appropriate combination of
mutants, and by selectively targeting GFP for cell puriﬁcation.
Perhaps most important, the collective expression data
obtained from such experiments provide vast amounts of
information about the various regulatory inputs to each
identiﬁed gene and allow detailed molecular signatures to be
derived for speciﬁc cells within a complex tissue.
Unanticipated Complexity of the Drosophila Muscle
Regulatory Network
Muscle FCs are speciﬁed by the convergent inputs of
multiple intercellular signals [10,17]. The differential expres-
sion of a few cell-speciﬁc markers has in the past suggested
that individual FCs have distinct signaling responses, causing
each to acquire a unique identity prior to its differentiation
into a particular muscle. With the discovery of substantially
more genes expressed in different FC subsets, the present
work substantiates this hypothesis. Moreover, earlier studies
anticipated that distinct but related transcriptional codes
would be responsible for different patterns of FC gene
expression [24,56]. This model is supported by recent
computational and empirical analyses of candidate cis-
regulatory modules associated with the FC genes newly
identiﬁed here (A. A. Philippakis, B. Busser, S. S. Gisselbrecht,
F. S. He, B. Estrada, A. M. Michelson, and M. L. Bulyk,
unpublished data).
In contrast to FCs, the FCM population has been thought to
be relatively homogeneous [15,16], an idea that is not
supported by our ﬁndings. Rather, this second myoblast class
is quite heterogeneous, and the control of FCM gene
expression—while having some common features—is not
uniform. For example, although transcription of most FCM
genes requires lmd, others are entirely lmd independent. Still
other FCM genes exhibit regional differences in their
responses to perturbations of Ras and Notch signaling, while
some lmd-dependent genes are not expressed in all FCMs in
which Lmd is found. Finally, a subset of FCM genes is
differentially controlled by Ras, Notch, and Lmd in the
somatic and visceral subdivisions of the mesoderm, even
though both types of muscle arise through fusion of similar
myoblasts [57].
FCs and FCMs were found to have gene expression
signatures comprising large numbers of unique genes, as well
as numerous shared transcripts. Whereas transcription
factors, signal transduction components, and adhesion
molecules are overrepresented in FCs, proteins associated
with metabolic functions predominate in both myoblast
classes. The prominent expression of regulatory genes in
FCs is in agreement with prior evidence that these myoblasts
contain speciﬁc determinants of muscle identity [18,42] and
suggests that cell fusion plays an important role in the
acquisition of unique genetic programs by individual
myotubes.
Functions of Newly Identified Myoblast Genes
The speciﬁc functions of each myoblast type are further
emphasized by our RNAi results. For example, sola—which
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protein—is expressed only in FCMs and is essential for
myoblast fusion. Moreover, proﬁlin, another actin binding
protein encoded by chic [48], is also restricted to FCMs. These
ﬁndings imply a different function or mode of regulation of
the actin cytoskeleton in FCMs as opposed to FCs during
fusion. While the cytoskeleton has previously been implicated
in myotube formation [58], an asymmetrically expressed
cytoskeletal component has not been uncovered, further
highlighting the unique nature of the cytoskeleton in these
myoblasts. In contrast, RNAi directed against the FC-speciﬁc
gene suel/CG17492 causes an early myospheroid phenotype in
a subset of muscles, suggesting a defect in myotube pathﬁnd-
ing and/or in formation of stable epidermal attachments,
functions characteristic of FCs [42].
Although whole-genome RNAi screens have proved to be
highly informative for C. elegans and for cultured cells where
efﬁcient dsRNA delivery methods are available [59], they are
technically much more difﬁcult to apply to Drosophila
embryos. Restricting a whole embryo RNAi screen to a list
of genes having tissue-speciﬁc expression patterns offers a
more efﬁcient approach to such functional discovery. This
concept can also be applied to large-scale RNAi analysis of
mouse embryonic development.
The experimental strategy presented here has provided
substantial insight into the complexity of components
involved in muscle development in the Drosophila embryo.
Many of our conclusions could only be drawn by examining
the large, interrelated datasets that comprise a targeted
expression proﬁle compendium. Other ﬁndings are derived
from more traditional studies of single genes that never-
theless depended on genomewide approaches for their
identiﬁcation. Further analysis of our existing results, and
expansion of this database by performing similar experi-
ments with additional informative genotypes and with small-
er subsets of puriﬁed cells, should yield even greater
knowledge of the architecture and function of the myogenic
network. Furthermore, application of this integrated set of
approaches in other developmental contexts, both in
Drosophila and in other model organisms, can offer a
systems-level view of cell fate speciﬁcation and morpho-
genesis that provides a wealth of hypotheses for further
testing by genetic and biochemical methods.
Materials and Methods
Fly strains and genetics. The following Drosophila stocks were used
to obtain both wild-type and genetically modiﬁed mesodermal cells
expressing GFP: twi-Gal4 UAS-2EGFP [30], UAS-ktop (constitutively
activated EGFR) [60], UAS-dof UAS-k-htl (constitutively activated
Heartless FGFR together with Downstream of FGFR/Heartbroken/
Stumps) [61,62], UAS-Ras1
Act (activated Ras) [18], UAS-pnt
P2VP16
(activated Pointed) [24], UAS-tkv
QD (activated Thick veins) [63],
UAS-arm
s10 (activated Armadillo)[64], UAS-arm
s10; UAS-Ras1
Act,
SG24 wg
CX4/CyO, wg
IG22 UAS-2EGFP, UAS-N
intra [65], twi-Gal4 lmd
1/
TM3 ftz-lacZ, UAS-2EGFP lmd
2/TM3 ftz-lacZ, twi-Gal4 Dl
X/TM3 ftz-lacZ,
and UAS-2EGFP Dl
X/TM3 ftz-lacZ. The following stocks were used to
determine gene expression patterns in mutant backgrounds: twi-Gal4,
UAS-Ras1
Act,D l
X/TM3 ftz-lacz, and lmd
1/TM3 ftz-lacz. The enhancer
trap line rp298lacz was used to test for localization of gene expression
to founder cells [32].
Fluorescence-activated sorting of cells from Drosophila embryos.
Freshly laid embryos were collected and aged to stage 11, at which
point a single cell suspension was prepared. Cells were separated into
GFP-positive and -negative cell populations using a ﬂow cytometer
(see Protocol S1 for details).
Microarray experiments and data analysis. Total cellular RNA (2.5
to 3 lg) was labeled in one round of linear ampliﬁcation and used for
hybridization to a single Affymetrix GeneChip using standard
methods recommended by the manufacturer (http://www.affymetrix.
com/support/technical/manual/expression_manual.affx). Each RNA
sample was independently labeled and hybridized in triplicate. A
detailed description of all computational methods used for analyzing
the expression data can be found in Protocol S1.
In situ hybridization and immunohistochemistry. Digoxigenin-
labeled antisense RNA probes were synthesized using cDNA clones
obtained from the Drosophila Gene Collection (DGC1 and DGC2,
http://www.fruitﬂy.org/DGC/index.html). For genes without an avail-
able cDNA, gene-speciﬁc PCR primers were designed. A microtiter
plate method was used for parallel synthesis of multiple probes
(http://www.fruitﬂy.org/about/methods/RNAinsitu.html). In calculat-
ing the true-positive detection rate for genes enriched in wild-type
GFP-expressing cells, we considered as true positive every gene
validated as having mesodermal expression by our in situ hybrid-
izations or annotated as such in the BDGP in situ database or in the
published literature (Table S1); a small number of genes were
included in this GFP-positive category that were found to be
expressed in nonmesodermal cells that nevertheless expressed GFP
at stage 11 under twi-Gal4 control (for example, due to GFP
perdurance in cells of the endodermal and mesectodermal primordia
in which twi is expressed at earlier stages [unpublished data]).
Antibody stainings were carried out as described [18] Rabbit anti-
Lmd (from H. Nguyen) was used at 1:1,000. Homozygous Dl or lmd
mutant embryos were identiﬁed using a lacZ-marked TM3 balancer
chromosome.
RNA interference assay. Gene segments for dsRNA synthesis were
selected to be 300 to 700 bp in length and common to all predicted
splice variants of the targeted gene and to lack any consecutive 18 bp
of identity to any other predicted gene. These sequences were PCR-
ampliﬁed from primary embryonic cDNA using primers that
incorporated T7 promoters on both ends (primer sequences are
available upon request). Puriﬁed PCR product was transcribed in
vitro and puriﬁed using the MEGAscript RNAi kit (Ambion, Austin,
Texas, United States), precipitated, resuspended, and diluted to 2 mg/
ml in DEPC-treated 13 injection buffer [40]. Dechorionated MHC-
tau-GFP embryos [41] were injected mid-ventrally during the
syncytial blastoderm stage, then allowed to develop to stage 16 to
17 before assessment. Each gene was initially injected and scored
blindly, with negative control (lacZ dsRNA) and positive control (mbc
or blow dsRNA) injections performed in parallel. Only embryos that
developed robust GFP expression and lacked obvious major
morphological defects (typically 60% to 80% of those injected) were
included in the analysis.
Supporting Information
Figure S1. Embryonic Expression Patterns of Selected Genes
Identiﬁed in Microarray Experiments as Being Enriched in Wild-
Type Mesoderm
RNA in situ hybridization shows that validated mesodermally
enriched genes are expressed in different populations of mesodermal
cells at stage 11, including somatic and visceral muscle precursors (A,
C, D–N, P and A, C–L, O, respectively), hemocytes (O), and cardiac
primordium (D, E, I, and L–N). Arrowhead (I) indicates representative
cardiac primordium; arrow (K) indicates visceral mesoderm; asterisk
(O) indicates hemocytes.
Found at DOI: 10.1371/journal.pgen.0020016.sg001 (3.0 MB PDF).
Figure S2. Supporting Figures for FC and FCM Gene Meta-Analyses
(A and C) Bar plot showing the weight of each genotype in the meta-
analysis to identify genes with FC- and FCM-like expression,
respectively (Protocol S1, Analysis E). Error bars show the standard
deviation of weights within the approximately 2,000 weight proﬁles
used to calculate each average weight proﬁle.
(B and D) Normalized median absolute deviation between the meta-
analysis gene rank (x-axis) and individual genotype ranks (Protocol S1,
Analysis F). The graph shows the average over all the genotypes, using
theweightsin(A)and(C),respectively.Theblackverticallinehighlights
the point at which the data cross the trend line (blue) derived from a
smoothing function (see Protocol S1, Analysis Method F).
Found at DOI: 10.1371/journal.pgen.0020016.sg002 (152 KB PDF).
Protocol S1. Experimental Procedures
Found at DOI: 10.1371/journal.pgen.0020016.sd001 (93 KB DOC).
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Myoblast Developmental Program AnalysisTable S1. Description of Mesodermally Enriched Genes; Validated
FC, FCM, and FC þ FCM Genes; and Results from In Situ Hybrid-
ization and RNAi Experiments
Found at DOI: 10.1371/journal.pgen.0020016.st001 (337 KB XLS).
Table S2. Meta-Analysis of the Transcriptional Proﬁling Data:
Ranking of All Affymetrix Probe Sets by FC- or FCM-Like Gene
Expression Pattern
Found at DOI: 10.1371/journal.pgen.0020016.st002 (5.9 MB XLS).
Table S3. Comparison of Top-Ranking FC and FCM Gene Lists in
Terms of GO Functional Category Enrichment
Found at DOI: 10.1371/journal.pgen.0020016.st003 (48 KB XLS).
Video S1. Inactivation of the FCM Gene CG2708 by Injection of
dsRNA Renders Embryos (right) Immotile When Compared with Age-
Matched Embryos Injected with an Inactive Control dsRNA (left)
Confocal images of GFP ﬂuorescence were collected at 5-s intervals
and presented at ﬁve frames per second.
Found at DOI: 10.1371/journal.pgen.0020016.sv001 (1.4 MB MOV).
Accession Numbers
Microarray data described in the text are available from the Gene
Expression Omnibus (www.ncbi.nlm.nih.gov/geo) with the accession
number GSE3854.
Flybase (www.ﬂybase.org) ID numbers for genes cited in the text
are eve, FBgn0000606; wg, FBgn0004009; dpp, FBgn0000490; Egfr,
FBgn0003731; htl, FBgn0010389; Ras85D, FBgn0003205; N,
FBgn0004647; lmd, FBgn0039039; Tl, FBgn0003717; twi, FBgn0003900;
duf, FBgn0028369; Dl, FBgn0000463; CG13503, FBgn0034695;
CG17492, FBgn0032742; CG2708, FBgn0010812; chic, FBgn0000308;
dof, FBgn0020299; ftz, FBgn0001077; blow, FBgn0004133; CG14207,
FBgn0031037; CG10275, FBgn0032683; CG10641, FBgn0032731;
NHP2, FBgn0029148; RpI135, FBgn0003278; sns, FBgn0024189; GFP,
FBgn0014446; Gal4, FBgn0014445; and lacZ, FBgn0014447.
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